225 related articles for article (PubMed ID: 94714)
1. Androgen receptors in benign and malignant prostatic tissue.
Lakey WH; Bruchovsky N; Callaway T; Comeau T; Lieskovsky G; Rennie P; Shnitka T; Wilkin P
Trans Am Assoc Genitourin Surg; 1979; 71():19-22. PubMed ID: 94714
[TBL] [Abstract][Full Text] [Related]
2. Dihydrotestosterone concentration in prostate cancer tissue as a predictor of tumor differentiation and hormonal dependency.
Geller J; Albert J; de la Vega D; Loza D; Stoeltzing W
Cancer Res; 1978 Nov; 38(11 Pt 2):4349-52. PubMed ID: 81107
[TBL] [Abstract][Full Text] [Related]
3. Protamine sulfate precipitation of androgen receptors in cytosols of human benign and malignant prostatic tumors.
Mobbs BG; Johnson IE; Connolly JG
Prog Clin Biol Res; 1979; 33():13-32. PubMed ID: 93749
[No Abstract] [Full Text] [Related]
4. The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer.
Nishiyama T; Hashimoto Y; Takahashi K
Clin Cancer Res; 2004 Nov; 10(21):7121-6. PubMed ID: 15534082
[TBL] [Abstract][Full Text] [Related]
5. Receptor proteins for androgens in prostatic disease.
Ghanadian R; Auf G; Chisholm GD; O'Donoghue EP
Br J Urol; 1978 Dec; 50(7):567-9. PubMed ID: 88985
[TBL] [Abstract][Full Text] [Related]
6. The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture.
Lippman M; Bolan G; Huff K
Cancer Res; 1976 Dec; 36(12):4610-8. PubMed ID: 1000506
[TBL] [Abstract][Full Text] [Related]
7. Testosterone-mediated increase in 5 alpha-dihydrotestosterone content, nuclear androgen receptor levels, and cell division in an androgen-independent prostate carcinoma of Noble rats.
Ho SM; Leav I; Damassa D; Kwan PW; Merk FB; Seto HS
Cancer Res; 1988 Feb; 48(3):609-14. PubMed ID: 3257169
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptors in male sex tissues of rats and humans.
Attramadal A; Weddington SC; Naess O; Djoseland O; Hansson V
Prog Clin Biol Res; 1976; 6():189-203. PubMed ID: 66689
[TBL] [Abstract][Full Text] [Related]
9. [Androgen receptor and 5 alpha-reductase activity in the epithelium and the stroma of human benign prostatic hyperplasia].
Oishi K; Okada K; Yoshida O; Romijn JC; Bolt de Vries J; Schröder FH
Hinyokika Kiyo; 1985 May; 31(5):785-90. PubMed ID: 2413745
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic and nuclear androgen receptors of human prostate.
Shain SA; Boesel RW; Radwin HM; Lamm DL
Prog Clin Biol Res; 1979; 33():33-49. PubMed ID: 93751
[No Abstract] [Full Text] [Related]
11. Androgen receptor binding and antiandrogenic activity of some 4,5-secoandrostanes and ring B cyclopropanoandrostanes.
Stárka L; Hampl R; Kasal A; Kohout L
J Steroid Biochem; 1982 Sep; 17(3):331-4. PubMed ID: 6215537
[TBL] [Abstract][Full Text] [Related]
12. Androgens and androgen-receptors in prostate tissue from patients with benign prostatic hyperplasia: effects of cyproterone acetate.
de Jong FH; Reuvers PJ; Bolt-de Vries J; Mulder E; Blom JH; Schroeder FH
J Steroid Biochem Mol Biol; 1992 Mar; 42(1):49-55. PubMed ID: 1373073
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor assays in advanced prostatic cancer.
Buttyan R; Olsson CA
Urol Clin North Am; 1984 May; 11(2):311-7. PubMed ID: 6375068
[TBL] [Abstract][Full Text] [Related]
14. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
Krieg M; Bartsch W; Thomsen M; Voigt KD
J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogens.
Whitaker HC; Hanrahan S; Totty N; Gamble SC; Waxman J; Cato AC; Hurst HC; Bevan CL
Clin Cancer Res; 2004 Nov; 10(21):7392-401. PubMed ID: 15534116
[TBL] [Abstract][Full Text] [Related]
16. Characterization and measurement of the androgen receptor in human benign prostatic hyperplasia and prostatic hyperplasia and prostatic carcinoma.
Snochowski M; Pousette A; Ekman P; Bression D; Andersson L; Högberg B; Gustafsson JA
J Clin Endocrinol Metab; 1977 Nov; 45(5):920-30. PubMed ID: 72758
[No Abstract] [Full Text] [Related]
17. Enzymatic and binding activities of 5 alpha-reductase and androgen receptors in hamster prostate.
Cabeza M; Bratoeff E; Heuze I; Ramírez E; Sánchez M; Flores E
Proc West Pharmacol Soc; 2003; 46():128-31. PubMed ID: 14699908
[No Abstract] [Full Text] [Related]
18. [Comparison of natural and synthetic ligands for determining androgen receptors in prostatic tumors and prostatic nodular hyperplasia].
Kushlinskiĭ NR; Bassalyk LS; Degtiar' VG
Med Radiol (Mosk); 1983 Aug; 28(8):13-6. PubMed ID: 6193390
[TBL] [Abstract][Full Text] [Related]
19. Androgen binding in cytosol and nucleus of cells from human benign hyperplastic prostate [proceedings].
Sirett DA; Grant JK
J Endocrinol; 1977 Dec; 75(3):25P. PubMed ID: 73566
[No Abstract] [Full Text] [Related]
20. Suppression of mutant androgen receptors by flutamide.
Ishioka J; Hara S; Isaacs JT; Tomura A; Nishikawa K; Kageyama Y
Int J Urol; 2009 May; 16(5):516-21. PubMed ID: 19389135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]